Gregg, J. R., Newcomb, L., Wu, R., Dennison, J., Davis, J. W., Pettaway, C., . . . Fahrmann, J. (2024). Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance. Biomarker Research, 12(1), 1. https://doi.org/10.1186/s40364-024-00678-7
Chicago-referens (17:e uppl.)Gregg, Justin R., et al. "Validation of a Prognostic Blood-based Sphingolipid Panel for Men with Localized Prostate Cancer Followed on Active Surveillance." Biomarker Research 12, no. 1 (2024): 1. https://doi.org/10.1186/s40364-024-00678-7.
MLA-referens (9:e uppl.)Gregg, Justin R., et al. "Validation of a Prognostic Blood-based Sphingolipid Panel for Men with Localized Prostate Cancer Followed on Active Surveillance." Biomarker Research, vol. 12, no. 1, 2024, p. 1, https://doi.org/10.1186/s40364-024-00678-7.
